This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Hologic (HOLX) Beats Earnings and Revenue Estimates in Q3
by Zacks Equity Research
Solid growth at Hologic's (HOLX) Breast Health and international business drives top line in Q3.
QIAGEN (QGEN) Beats Earnings and Revenue Estimates in Q2
by Zacks Equity Research
QIAGEN's (QGEN) year-over-year revenue growth in Q2 is encouraging. Expansion in operating margin buoys optimism.
Fresenius Medical (FMS) Misses Q2 Earnings & Sales Estimates
by Zacks Equity Research
Lower peritoneal dialysis sales in Q2 hurt Fresenius Medical (FMS); solid geographical performance encourages.
Medical Product Earnings Lineup for Aug 2: ABC, BDX & More
by Zacks Equity Research
Strong R&D focus is likely to be the key driver of the Medical Product space in Q2.
Ecolab (ECL) Q2 Earnings In Line, Revenues Beat Estimates
by Zacks Equity Research
Solid performance in the Global Industrial and Global Institutional segments boost Ecolab's (ECL) top line in Q2.
Illumina (ILMN) Beats on Q2 Earnings, Lifts '18 Guidance
by Zacks Equity Research
Illumina (ILMN) gains on strong consumables growth across its sequencing portfolio with strength in all throughput categories in Q2.
Cardiovascular Systems (CSII) Beats on Q4 Earnings & Revenues
by Zacks Equity Research
Cardiovascular Systems (CSII) sees strength in Coronary device and peripheral device segments in Q4.
athenahealth (ATHN) Beats on Q2 Earnings, Raises '19 View
by Zacks Equity Research
An upbeat 2018 guidance instills investor's optimism for athenahealth (ATHN). However, lackluster performance in the Implementation and other segment is a persistent headwind.
The Zacks Analyst Blog Highlights: Apple, Microsoft, Intuitive Surgical and AT&T
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Apple, Microsoft, Intuitive Surgical and AT&T
Apple Reports: Global Week Ahead
by John Blank
The FAANG stock Apple (AAPL) is the biggest earnings report I see looming this week.
Abiomed Gets CDSCO Nod for Impella Heart Pumps in India
by Zacks Equity Research
Abiomed's (ABMD) Impella gets regulatory approval in India; prospects in APAC look upbeat.
Edwards Lifesciences (EW) Q2 Earnings Beat, Revenues Miss
by Zacks Equity Research
Edwards Lifesciences (EW) gains from THVT strength on continued therapy adoption across all geographies in Q2.
Omnicell (OMCL) Earnings & Revenues Beat Estimates in Q2
by Zacks Equity Research
Omnicell's (OMCL) second-quarter 2018 performance impresses with year-over-year growth in earnings and revenues.
Zacks.com highlights: Intuitive Surgical, Celanese, Great Southern Bancorp, Mellanox Technologies and Align Technology
by Zacks Equity Research
Zacks.com highlights: Intuitive Surgical, Celanese, Great Southern Bancorp, Mellanox Technologies and Align Technology
5 Top-Ranked Stocks Picked via Driehaus Strategy
by Zacks Equity Research
We have used Driehaus strategy to select the top momentum stocks using the "buy high and sell higher" rule.
Has Intuitive Surgical (ISRG) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (ISRG) Outperforming Other Medical Stocks This Year?
The Zacks Analyst Blog Highlights: Johnson & Johnson, Nike, Schlumberger, CSX and Intuitive Surgical
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Johnson & Johnson, Nike, Schlumberger, CSX and Intuitive Surgical
Top Analyst Reports for Johnson & Johnson, Nike & Schlumberger
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Johnson & Johnson (JNJ), Nike (NKE) and Schlumberger (SLB).
Intuitive Surgical (ISRG) Beats on Q2 Earnings & Revenues
by Zacks Equity Research
Strong performance in the Instruments & Accessories as well as Systems segments drove Intuitive Surgical's (ISRG) top line in Q2.
Intuitive Surgical (ISRG) Loses 0.9% Ahead of Earnings: What To Expect
by Ryan McQueeney
Shares of Intuitive Surgical (ISRG) fell about 0.9% in morning trading Thursday, just hours before the innovative medical equipment maker is set to release its latest quarterly earnings report. Here's what to expect this afternoon.
The 5 Most Spectacular Earnings Charts This Week
by Tracey Ryniec
These stocks are among the hottest on the Street. Can they keep their upward momentum?
Trump's APAC Focus Puts Spotlight on These 3 MedTech Stocks
by Sreyoshi Mukherjee
Despite the trade war upheaval in Asia, some medical device companies stand strong in the APAC region.
Here's Why You Should Hold Intuitive Surgical (ISRG) Stock
by Zacks Equity Research
Strong performance by Intuitive Surgical's (ISRG) flagship da Vinci system is a key growth driver. However, the company faces stiff competition in the niche space.
BD Buys TVA Medical, To Provide Minimally Invasive Procedure
by Zacks Equity Research
The acquisition of TVA Medical will enable Becton, Dickinson (BDX) to treat patients with chronic kidney disease through minimally invasive procedures.
Intuitive Surgical's FDA Approval for SureForm to Aid Surgery
by Zacks Equity Research
Intuitive Surgical's (ISRG) SureForm 60 stapler receives FDA approval; strengthens its profile for minimally invasive surgical solutions.